Issue brief |

HIV & opportunistic infection treatment: Spotlight on access gaps

Photograph by Guillaume Binet/MYOP

This issue brief provides information regarding the changing product landscape, and updates on pricing and access to three critical medical interventions: optimal HIV therapy with dolutegravir; paediatric HIV therapy; and opportunities to improve treatment for two common opportunistic infections: cryptococcal meningitis and Kaposi’s sarcoma.

Additional publications in the Untangling the Web report series are available here.

Learn more about MSF’s work to improve access to lifesaving HIV treatment.

HIV & opportunistic infection treatment: Spotlight on access gaps

/